Search company, investor...

Glucose Sensing Technologies

glucosesensingtechnologies.com

Stage

Other Investors | Alive

About Glucose Sensing Technologies

Vytrace Corporation (fka Glucose Sensing Technologies) is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

Headquarters Location

1343 Beulah Road

Pittsburgh, Pennsylvania, 15235,

United States

Missing: Glucose Sensing Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Glucose Sensing Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Glucose Sensing Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Glucose Sensing Technologies is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,898 items

Glucose Sensing Technologies Frequently Asked Questions (FAQ)

  • Where is Glucose Sensing Technologies's headquarters?

    Glucose Sensing Technologies's headquarters is located at 1343 Beulah Road, Pittsburgh.

  • What is Glucose Sensing Technologies's latest funding round?

    Glucose Sensing Technologies's latest funding round is Other Investors.

  • Who are the investors of Glucose Sensing Technologies?

    Investors of Glucose Sensing Technologies include Pittsburgh Life Sciences Greenhouse.

  • Who are Glucose Sensing Technologies's competitors?

    Competitors of Glucose Sensing Technologies include Senseonics, Cardiopulmonary, WellAware Systems, GlySure, BMEYE and 16 more.

Compare Glucose Sensing Technologies to Competitors

V
Vytrace

Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

N
Novoculi

Located in Hanover, NH and San Francisco, CA, Novoculi is a medical device company focused on developing a non-invasive, optical blood glucose monitor. Novoculi's Noninvasive Blood Glucose Monitor aims to build on physiologically demonstrated optical phenomena which forms the basis for Novoculi's technology. Novoculi hopes to leverage its technology to develop a non-invasive blood glucose monitor which will allow its patient population to better manage their blood glucose without a painful finger stick.

B
Biowatch Medical

Biowatch Medical is the producer of "Sentry" a wearable vital signs monitor

L
Luminous Medical

Luminous Medical is developing a new device to allow the near continuous measurement of blood glucose and other analytes in the hospital environment.

S
Sotera Wireless

Sotera Wireless is committed to the development, marketing and sale of a new generation early detection surveillance monitoring system. Its flagship product, the ViSi Mobile, is designed to improve patient safety by detecting early signs of deterioration in virtually any care setting, enabling early intervention and rapid response without limiting the patient's freedom of movement

Bay Area Digital Logo
Bay Area Digital

Bay Area Digital is a company that received a SBIR Phase I grant for a project entitled: Talking Blood Glucose Meter with full Accessibility for Blind, Visually and Cognitively Impaired. Their Project addresses a crisis in the lack of effective glucose monitoring equipment for visually and cognitively impaired diabetics. The proposal thoroughly examines the technical and commercial feasibility of developing innovative technology that enables such patients to reliably use information provided by a state-of-the-art blood glucose meter, using speech output that is coupled with a commercially developed meter. There are currently no state-of-the-art or best-of-breed blood glucose meter systems available in the U.S. market with speech capabilities for use by the cognitively, visually impaired or blind community. The development of such a meter will positively impact the self-management of diabetes mellitus, improving quality of life and clinical outcomes for patients and preventing the development of secondary complications and provide an opportunity to impact a major health problem affecting millions of U.S. citizens.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.